# Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

> **NCT02242630** · NA · COMPLETED · sponsor: **Keesler Air Force Base Medical Center** · enrollment: 61 (actual)

## Conditions studied

- Subacromial Bursitis
- Shoulder Pain

## Interventions

- **DRUG:** Methylprednisolone, 20 mg
- **DRUG:** Methylprednisolone, 40 mg
- **DRUG:** Triamcinolone, 20 mg
- **DRUG:** Triamcinolone, 40 mg

## Key facts

- **NCT ID:** NCT02242630
- **Lead sponsor:** Keesler Air Force Base Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242630, "Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02242630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*